It is possible that RUNX1 may cooperate with SP1 to promote PKCβ gene expression in CLL cells because SP1 is shown to interact with the DNA binding domain of RUNX1 to facilitate expression of other genes in other cell types51. Here, SP1 is linked to B-cell chronic lymphocytic leukemia.